Qube Research & Technologies LTD Cara Therapeutics, Inc. Transaction History

Qube Research & Technologies LTD

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 13, 2023	SELL	$1.67 - $3.33 $139,381 - $277,928	-83,462 Reduced 96.19%	3,305 $5,000
Q2 2023 Aug 14, 2023	BUY	$2.83 - $4.94 $202,650 - $353,743	71,608 Added 472.38%	86,767 $245,000
Q1 2023 May 15, 2023	BUY	$4.89 - $12.27 $74,127 - $186,000	15,159 New	15,159 $74,000
Q3 2022 Nov 14, 2022	SELL	$8.24 - $12.56 $363,738 - $554,436	-44,143 Reduced 58.38%	31,466 $295,000
Q2 2022 Aug 15, 2022	BUY	$7.45 - $13.84 $436,502 - $810,899	58,591 Added 344.29%	75,609 $690,000

Q1 2022 May 09, 2022	BUY	$9.94 - $12.65 $169,158 - $215,277	17,018 New	17,018 $207,000

102

21.5M

50K

Ticker CARA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 53,725,900
Market Cap $17.7M
Description
Cara Therapeutics, Inc., an early commercial-stage biopharmaceutical company, focuses on developing and commercializing chemical entities with a primary focus on pruritus and pain by selectively targeting kappa opioid receptors in the United States. The company is developing product candidates that target the body's peripheral nervous system and...

Get notified when there are updates to the investment portfolio of Qube Research & Technologies LTD, based on Form 13F filings with the SEC.

Stay updated on Qube Research & Technologies LTD with notifications on news.